Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 9,461–9,480 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass I

Gaia Kratom (mitragyna speciosa) powder, Green Horn, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com

by Gaia Ethnobotanical LLC

Reason
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Recall initiated
June 20, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass I

Gaia Kratom (mitragyna speciosa) powder, Green Dragon, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com

by Gaia Ethnobotanical LLC

Reason
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Recall initiated
June 20, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass I

Gaia Kratom (mitragyna speciosa) powder, Ganesh, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com

by Gaia Ethnobotanical LLC

Reason
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Recall initiated
June 20, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass I

Gaia Kratom (mitragyna speciosa) powder, Elephant, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com

by Gaia Ethnobotanical LLC

Reason
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Recall initiated
June 20, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass I

Gaia Kratom (mitragyna speciosa) powder, Bali Gold, 1oz, 250g 1kg packages, Gaia Ethnobotanical.com

by Gaia Ethnobotanical LLC

Reason
Microbal Contamination of Non-Sterile Product; FDA analysis found salmonella contamination
Recall initiated
June 20, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass III

Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals, Inc. Morgantown, WV 26505, NDC 0378-1352-01

by Mylan Pharmaceuticals Inc.

Reason
Subpotent Drug
Recall initiated
July 9, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Nitrofurantoin Oral Suspension USP, 25mg/5mL, 230 mL Bottle, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, UPC 343386-450-114, NDC 43386-450-11

by LUPIN SOMERSET

Reason
Subpotent Drug and Failed Content Uniformity.
Recall initiated
June 28, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide within the US

View recall →

Drug Recall Ongoing Historical recordClass II

Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00

by Sanofi-Aventis U.S. LLC

Reason
Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
Recall initiated
July 5, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Potassium Chloride For Injection Concentrate syringe 40 mEq/20 mL (2 mEq/mL), Rx only, Medi-Fare Drug Pharmaceutical Compounding 300 West Pine St., Blacksburg, SC 29702 800-622-0007

by Medi-Fare Drug and Home Health Center

Reason
CGMP Deviations: Syringes were filled with 19mL of potassium chloride when the labels displayed a fill of 20mL.
Recall initiated
July 3, 2018
Reported by FDA
July 18, 2018
Distribution
Texas only

View recall →

Drug Recall Terminated Historical recordClass II

Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Concentration=10 mg/mL) 0.25 mL Total Volume, Rx only , SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205 877-550-5059

by SCA Pharmaceuticals

Reason
Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
Recall initiated
June 29, 2018
Reported by FDA
July 18, 2018
Distribution
United States

View recall →

Drug Recall Terminated Historical recordClass II

Monsel's Solution (Ferric Subsulfate), 20%, packaged as 12 single application vials and 12 applicators, 8 mL per box, Manufactured For: MedGyn Products, Inc., 100 W. Industrial Rd., Addison, IL 60101 USA; Manufactured By: BioDiagnostics Intl, 555 West Lambert Road Unit-C, Brea, CA 92821, NDC 42721-112-08.

by Medgyn Products, Inc.

Reason
CGMP Deviations: The manufacturer of this product recalled because they were not manufactured under current good manufacturing practices.
Recall initiated
July 3, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide in the USA, Barbados, Cayman Islands, Chile, Cyprus, Ecuador, El Salvador, Guatemala, Hong Kong, Kuwait, Lebanon, Malaysia, Maldives, Mexico, Mongolia, Montenegro, Mozambique, Pakistan, Paraguay, Peru, Republic of Georgia, Serbia, South Africa, Tanzania, United Arab Emirates, Venezuela, and Vietnam.

View recall →

Drug Recall Terminated Historical recordClass II

Acetylcysteine for Injection 6 g/30 mL (200 mg/mL). Rx Only. Manufactured by Akron Inc., Lake Forest, IL 60045. NDC 17478-660-30.

by Akorn, Inc.

Reason
CGMP Deviations
Recall initiated
June 22, 2018
Reported by FDA
July 18, 2018
Distribution
U.S. Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Enalapril Maleate Tablets USP, 5 mg, 100 Tablets (10X10) blister cards, 12 cartons in a shipper, Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- NDC 68084-390-01 Carton [68084-390-11 - Unit Dose]

by American Health Packaging

Reason
Failed Impurities/Degradation Specification; out-of-specification results for the Enalapril DKT degradant
Recall initiated
June 25, 2018
Reported by FDA
July 18, 2018
Distribution
Lot#166023 products distributed from 12/29/16 to 1/19/17 and Lot#168467 distributed from 4/6/17 to 9/11/17. Distributors are the wholesalers who received the product; others are the Corporate Offices for those wholesalers.

View recall →

Drug Recall Terminated Historical recordClass III

Enalapril Maleate Tablets USP; 2.5 mg NDC code 64679-923-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons.

by Wockhardt Limited

Reason
Failed Impurities/Degradation Specifications
Recall initiated
June 19, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass III

Enalapril Maleate Tablets USP; 5 mg NDC code 64679-924-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons.

by Wockhardt Limited

Reason
Failed Impurities/Degradation Specifications
Recall initiated
June 19, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Fluocinolone Acetonide Topical Solution, USP, 0.01%, 60 mL bottle, Rx Only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108 USA; Distributed by: Actavis Pharmac, Inc., Parsippany, NJ 07054 USA, NDC 0591-2990-60.

by Teva Pharmaceuticals USA

Reason
Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.
Recall initiated
July 5, 2018
Reported by FDA
July 18, 2018
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass I

Neostigmine Methylsulfate Injection Solution, 3 mg per 3 mL, 1 mg per mL, 3 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile Services, ICB Laboratories, 8710 E 34th St. N., Wichita, KS 67205, NDC 71266-2003-01.

by Fagron Compounding Services LLC dba Fagron Sterile Services

Reason
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.
Recall initiated
June 29, 2018
Reported by FDA
July 11, 2018
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass I

Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile Services, ICB Laboratories, 8710 E 34th St. N., Wichita, KS 67205, NDC 71266-2003-02.

by Fagron Compounding Services LLC dba Fagron Sterile Services

Reason
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.
Recall initiated
June 29, 2018
Reported by FDA
July 11, 2018
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

eb5 Skincare that Works. Age Spot Treatment. Skin Lightening Cream with 2% Hydroquinone. 177.4 ml / 6 fl oz carton containing a tube. Manufactured For: EB5 Corporation Portland, OR 97210 Carton Bar Code: 7 41099 00009 9

by Eb5 Corporation

Reason
Failed Stability Specifications: Out-of-specification for viscosity, pH and specific gravity
Recall initiated
June 22, 2018
Reported by FDA
July 11, 2018
Distribution
Distributed Nation Wide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

Equate ClearLAX, Polyethylene Glycol 3350 Powder for Solution, OS Osmotic Laxative, OTC, packaged in a) 119 g bottle (NDC 49035-312-07), b) 238 g bottle (NDC 49035-312-08), Distributed by: Wal-mart Stores, Inc., Bentonville, AR 72716

by LUPIN SOMERSET

Reason
Labeling: Not Elsewhere Classified - A private label distributor noted unfiled NDC numbers on EQ ClearLax Polyethylene Glycol 3350 NF Powder Solution of various sizes.
Recall initiated
June 13, 2018
Reported by FDA
July 11, 2018
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.